Director/PDMR Shareholding

RNS Number : 3741K

Medaphor Group PLC

13 December 2018

 

13 December 2018

MedaPhor Group plc

("MedaPhor" or the "Group" or the "Company")

Director and PCA Dealings

Further to the Company's announcements on 26 November 2018 and 12 December 2018, MedaPhor announces that certain Directors, persons closely associated ("PCA") with them and an employee have, following Admission today, acquired a total of 1,847,064 ordinary shares of 1 pence each in the Company ("Ordinary Shares") via the Placing:

Name	Title	Number of Placing Shares subscribed for	Value of Placing Shares subscribed for	Resulting shareholding following subscription	Percentage of enlarged share capital following subscription
Riccardo Pigliucci	Non-Executive Chairman	117,648	£   10,000.08	117,648	0.1%
Stuart Gall	Chief Executive Officer	588,236	£   50,000.06	628,236	0.4%
Wilson Jennings	Finance Director	294,118	£   25,000.03	294,118	0.2%
Nicholas Sleep	Chief Technology Officer	176,471	£   15,000.04	226,471	0.1%
Ian Whittaker	Chief Operating Officer	117,648	£   10,000.08	349,982	0.2%
Nick Avis*	Non-Executive Director	141,177	£   12,000.06	341,177	0.2%
Andrew Barker	Non-Executive Director	117,648	£   10,000.08	317,992	0.2%

* Nick Avis' subscription has been made via his children: Alice Avis, Florence Avis and Harriet Avis who have each subscribed for 47,059 Placing Shares. Alice, Florence and Harriet are considered to be persons closely associated with Nick Avis.

The Company makes the following disclosures in accordance with article 19(3) of the Market Abuse Regulation:

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	1.   Riccardo Pigliucci 2.   Stuart Gall 3.   Wilson Jennings 4.   Nicholas Sleep 5.   Ian Whittaker 6.   Alice Avis 7.   Florence Avis 8.   Harriet Avis 9.   Andrew Barker
2	Reason for the notification
a)	Position/status	1.   Non-Executive Chairman 2.   Chief Executive Officer 3.   Finance Director 4.   Chief Technology Officer 5.   Chief Operating Officer 6.   Person closely associated with Nick Avis (Non-Executive Director) 7.   Person closely associated with Nick Avis (Non-Executive Director) 8.   Person closely associated with Nick Avis (Non-Executive Director) 9.   Non-Executive Director
b)	Initial notification /Amendment	Initial
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MedaPhor Group plc
b)	LEI	213800K4ZVWL4ZYQAZ70
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of 1 pence each ISIN: GB00BN791Q39
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 1.   8.5 pence 2.   8.5 pence 3.   8.5 pence 4.   8.5 pence 5.   8.5 pence 6.   8.5 pence 7.   8.5 pence 8.   8.5 pence 9.   8.5 pence 1.   117,648 2.   588,236 3.   294,118 4.   176,471 5.   117,648 6.   47,059 7.   47,059 8.   47,059 9.   117,648
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	13 December 2018
f)	Place of the transaction	London Stock Exchange, XLON

Enquiries:

MedaPhor Group plc	www.medaphor.com
Stuart Gall, CEO  Wilson Jennings, CFO	Tel: [phone]
Cenkos Securities - Nominated Advisor and broker	Tel:  [phone]
Mark Connelly / Cameron MacRitchie (Corporate Finance)
Michael Johnson / Julian Morse (Sales)
Walbrook PR	Tel: [phone] or [e-mail]
Anna Dunphy / Paul McManus	Mob: [phone] / Mob: [phone]

 

END

 

 

DSHLIFFTFTLVLIT